期刊
PLOS MEDICINE
卷 9, 期 7, 页码 -出版社
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pmed.1001232
关键词
-
资金
- National Institutes of Health (NIH) [R01 AI083059]
- Royal Society
- Medical Research Council
- HIV Prevention Trials Network [HPTN 052]
- National Institutes of Health [R37 DK049381]
- Center for HIV/AIDS Vaccine Immunology
- University of North Carolina at Chapel Hill Center for AIDS Research (CFAR)
- NIH [P30 AI50410]
- Medical Research Council [G0800596, G0600719, G0600719B] Funding Source: researchfish
- MRC [G0600719, G0800596] Funding Source: UKRI
Universal HIV testing and immediate antiretroviral therapy for infected individuals has been proposed as a way of reducing the transmission of HIV and thereby bringing the HIV epidemic under control. It is unclear whether transmission during early HIV infection-before individuals are likely to have been diagnosed with HIV and started on antiretroviral therapy-will compromise the effectiveness of treatment as prevention. This article presents two opposing viewpoints by Powers, Miller, and Cohen, and Williams and Dye, followed by a commentary by Fraser.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据